Ingelheim, 10 July, 2012 – In future patients with certain diseases, especially chronic ones, should be treated in a more holistic approach beyond drug treatment only. Thus Boehringer Ingelheim is concentrating on new business models and healthcare innovation and just signed a contract with the US company Healthrageous, Inc., a digital health management company.
Both companies will evaluate in a pilot study a lifestyle behavior modification program to improve the health status of people with diabetes Type 2. Study participants will experience a digital technology intervention combining digital coaching and a wireless glucose meter transmitting data to clinical monitors. The Internet-based tool will allow an evaluation of the intervention on changes in lifestyle behaviors, glucose control, additional medical parameters and medication adherence.